CCJ · NYSE · STOCK
Cameco (CCJ) Stock Analysis
$88.06
52W $77.70 – $135.24
52/100
$38.35B
153.6
1.06
Is CCJ Bullish or Bearish?
Mixed.
Innellis AI committee rates Cameco Corporation (CCJ) Watch with a composite score of 52/100
, based on 6 analysts with 50% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +7.74 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -12.26 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is genuinely divided. Risk Analyst sees a compelling case — low leverage (debt-to-equity 0.14) -- balance sheet can absorb a shock. Growth Analyst remains cautious — revenue declining -2.7% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull & Bear Case
Bull Case
- MACD histogram positive -- bullish momentum — Technical
- Low leverage (debt-to-equity 0.14) -- balance sheet can absorb a shock — Risk
- News sentiment is positive (+0.20 across 35 articles, 14d) — News
Bear Case
- P/E of 154.1 is expensive by classic value standards — Value
- Price-to-book of 8.2x prices in significant intangible value — Value
- Revenue declining -2.7% YoY -- this is not a growth story right now — Growth
- EPS declining -33.5% YoY despite any revenue growth — Growth
- 2 consecutive earnings misses -- execution concerns — Growth
- Price structure making lower highs and lower lows — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
52/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 87%
of 93 Energy peers
Value Analyst
bearish
40
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 154.1 is expensive by classic value standards
Growth Analyst
bearish
18
/ 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− Revenue declining -2.7% YoY -- this is not a growth story right now
Technical Analyst
neutral
46
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− Price structure making lower highs and lower lows
Risk Analyst
bullish
80
/ 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
+ Low leverage (debt-to-equity 0.14) -- balance sheet can absorb a shock
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
64
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.20 across 35 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 51.9 to 52.3.
- New bearish signals: 1 appeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
45.9
Neutral
MACD Histogram
0.180
Bullish Momentum
Trend Direction
Downtrend
Weekly: Uptrend
Market Structure
Mixed
Support
$83.21
Resistance
$110.12
Bollinger %B
0.37
Inside Bands
Price vs Moving Averages
EMA 9
$88.43
Below
EMA 21
$90.27
Below
EMA 50
$93.46
Below
EMA 200
$97.56
Below
Fundamental Analysis
Valuation
35
Growth
24
Profitability
42
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
153.6×
P/B Ratio
7.67×
PEG Ratio
-4.61
Dividend Yield
0.19%
52W High
$135.24
52W Low
$77.70
Quality & Growth
ROE
854.0%
ROA
572.3%
Gross Margin
2757.4%
Operating Margin
1425.5%
Revenue Growth YoY
—
Debt / Equity
0.14
AI Fundamental Assessment
P/E ratio of 153.6 (rich relative to a 15-40x range); Price-to-book of 7.7x; PEG ratio of -4.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 8.5%; Return on assets of 5.7%; Net margin of 10.2%; Gross margin of 27.6%; Current ratio of 3.06 (healthy short-term liquidity); Debt-to-equity of 0.14; Free cash flow per share is positive (1.16); Most recent quarter missed estimates by 52.7%; 2 consecutive earnings misses; EPS growth roughly steady (-40.0% -> -40.0% QoQ); Analyst estimates falling over recent quarters
Get the Full CCJ Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →